These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 2785820)

  • 21. Glucose utilization in the temporal cortex of affectively ill patients: positron emission tomography.
    Post RM; DeLisi LE; Holcomb HH; Uhde TW; Cohen R; Buchsbaum MS
    Biol Psychiatry; 1987 May; 22(5):545-53. PubMed ID: 3495297
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Limbic dysfunction in schizophrenia and mania. A study using 18F-labelled fluorodeoxyglucose and positron emission tomography.
    al-Mousawi AH; Evans N; Ebmeier KP; Roeda D; Chaloner F; Ashcroft GW
    Br J Psychiatry; 1996 Oct; 169(4):509-16. PubMed ID: 8894204
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stability of resting deoxyglucose metabolic values in PET studies of schizophrenia.
    Bartlett EJ; Barouche F; Brodie JD; Wolkin A; Angrist B; Rotrosen J; Wolf AP
    Psychiatry Res; 1991 May; 40(1):11-20. PubMed ID: 1946838
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regional metabolism in microsmic patients with schizophrenia.
    Clark C; Kopala L; Hurwitz T; Li D
    Can J Psychiatry; 1991 Nov; 36(9):645-50. PubMed ID: 1685350
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Single photon emission computed tomography (SPECT) measures of brain function in schizophrenia.
    Gordon E; Barry RJ; Anderson J; Fawdry R; Yong C; Grunewald S; Meares RA
    Aust N Z J Psychiatry; 1994 Sep; 28(3):446-52. PubMed ID: 7893239
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acute d-amphetamine challenge in schizophrenia: effects on cerebral glucose utilization and clinical symptomatology.
    Wolkin A; Sanfilipo M; Angrist B; Duncan E; Wieland S; Wolf AP; Brodie JD; Cooper TB; Laska E; Rotrosen JP
    Biol Psychiatry; 1994 Sep; 36(5):317-25. PubMed ID: 7993958
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cerebral metabolic consequences of electrical cutaneous stimulation in normal individuals.
    Buchsbaum MS; Holcomb HH; Johnson J; King AC; Kessler R
    Hum Neurobiol; 1983; 2(1):35-8. PubMed ID: 6603452
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Glucose metabolic correlates of continuous performance test performance in adults with a history of infantile autism, schizophrenics, and controls.
    Siegel BV; Nuechterlein KH; Abel L; Wu JC; Buchsbaum MS
    Schizophr Res; 1995 Sep; 17(1):85-94. PubMed ID: 8541254
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of attention on frontal distribution of delta activity and cerebral metabolic rate in schizophrenia.
    Guich SM; Buchsbaum MS; Burgwald L; Wu J; Haier R; Asarnow R; Nuechterlein K; Potkin S
    Schizophr Res; 1989; 2(6):439-48. PubMed ID: 2487185
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regional cerebral glucose metabolism in three sets of identical twins with psychotic symptoms.
    Clark C; Klonoff H; Tyhurst JS; Li D; Martin W; Pate BD
    Can J Psychiatry; 1989 May; 34(4):263-70. PubMed ID: 2786742
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regional cerebral glucose metabolism in major depressive disorder.
    Hurwitz TA; Clark C; Murphy E; Klonoff H; Martin WR; Pate BD
    Can J Psychiatry; 1990 Nov; 35(8):684-8. PubMed ID: 2282619
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Positron tomography demonstrates frontal lobe hypometabolism in progressive supranuclear palsy.
    Goffinet AM; De Volder AG; Gillain C; Rectem D; Bol A; Michel C; Cogneau M; Labar D; Laterre C
    Ann Neurol; 1989 Feb; 25(2):131-9. PubMed ID: 2784043
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regional cerebral glucose metabolism in autopsy-confirmed Creutzfeldt-Jakob disease.
    Matochik JA; Molchan SE; Zametkin AJ; Warden DL; Sunderland T; Cohen RM
    Acta Neurol Scand; 1995 Feb; 91(2):153-7. PubMed ID: 7785428
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regional cerebral glucose utilization in chronic organic mental disorders associated with alcoholism.
    Martin PR; Rio D; Adinoff B; Johnson JL; Bisserbe JC; Rawlings RR; Rohrbaugh JW; Stapleton JM; Eckardt MJ
    J Neuropsychiatry Clin Neurosci; 1992; 4(2):159-67. PubMed ID: 1627977
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [18F]fluorodeoxyglucose positron emission tomography in refractory complex partial seizures.
    Theodore WH; Newmark ME; Sato S; Brooks R; Patronas N; De La Paz R; DiChiro G; Kessler RM; Margolin R; Manning RG
    Ann Neurol; 1983 Oct; 14(4):429-37. PubMed ID: 6416141
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reduced temporal lobe glucose metabolism in aging.
    Eberling JL; Nordahl TE; Kusubov N; Reed BR; Budinger TF; Jagust WJ
    J Neuroimaging; 1995 Jul; 5(3):178-82. PubMed ID: 7626826
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of regional brain metabolism in bulimia nervosa and affective disorder assessed with positron emission tomography.
    Hagman JO; Buchsbaum MS; Wu JC; Rao SJ; Reynolds CA; Blinder BJ
    J Affect Disord; 1990 Jul; 19(3):153-62. PubMed ID: 2145335
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of sertraline on regional metabolic rate in patients with affective disorder.
    Buchsbaum MS; Wu J; Siegel BV; Hackett E; Trenary M; Abel L; Reynolds C
    Biol Psychiatry; 1997 Jan; 41(1):15-22. PubMed ID: 8988791
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A PET study of the pathophysiology of negative symptoms in schizophrenia. Positron emission tomography.
    Potkin SG; Alva G; Fleming K; Anand R; Keator D; Carreon D; Doo M; Jin Y; Wu JC; Fallon JH
    Am J Psychiatry; 2002 Feb; 159(2):227-37. PubMed ID: 11823264
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Asymmetry of temporal lobe phosphorous metabolism in schizophrenia: a 31phosphorous magnetic resonance spectroscopic imaging study.
    Deicken RF; Calabrese G; Merrin EL; Vinogradov S; Fein G; Weiner MW
    Biol Psychiatry; 1995 Sep; 38(5):279-86. PubMed ID: 7495921
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.